Verona Pharma Plc - ADR
VRNA
Market Cap$6.9B
Close$
$34.84
57.1% downside
Current Fair Value
57.1% downsideOvervalued by 57.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.90 Billion |
|---|---|
| Enterprise Value | $6.51 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.16 |
| Beta | 0.21 |
| Outstanding Shares | 84,925,625 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -42.04 |
|---|---|
| PEG | 114.57 |
| Price to Sales | 81.2 |
| Price to Book Ratio | 40.6 |
| Enterprise Value to Revenue | 54.92 |
| Enterprise Value to EBIT | -32.33 |
| Enterprise Value to Net Income | -40 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Verona Pharma Plc
CEO: David Zaccardelli